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Foreword 
The present report aims to provide a comprehensive picture of the pandemic situation of COVID-19 in the 
EU countries, and to be able to foresee the situation in the next coming days. 
We employ an empirical model, verified with the evolution of the number of confirmed cases in previous 
countries where the epidemic is close to conclude, including all provinces of China. The model does not 
pretend to interpret the causes of the evolution of the cases but to permit the evaluation of the quality of 
control measures made in each state and a short-term prediction of trends. Note, however, that the effects 
of the measures’ control that start on a given day are not observed until approximately 7-10 days later. 
 The model and predictions are based on two parameters that are daily fitted to available data: 
 a: the velocity at which spreading specific rate slows down; the higher the value, the better the 
control.  
 K: the final number of expected cumulated cases, which cannot be evaluated at the initial stages 
because growth is still exponential. 
We show an individual report with 8 graphs and a table with the short-term predictions for different 
countries and regions. We are adjusting the model to countries and regions with at least 4 days with more 
than 100 confirmed cases and a current load over 200 cases. The predicted period of a country depends on 
the number of datapoints over this 100 cases threshold, and is of 5 days for those that have reported more 
than 100 cumulated cases for 10 consecutive days or more. For short-term predictions, we assign higher 
weight to last 3 points in the fittings, so that changes are rapidly captured by the model. The whole 
methodology employed in the inform is explained in the last pages of this document. 
In addition to the individual reports, the reader will find an initial dashboard with a brief analysis of the 
situation in EU-EFTA-UK countries, some summary figures and tables as well as long-term predictions for 
some of them, when possible. These long-term predictions are evaluated without different weights to data-
points. We also discuss a specific issue every day.  
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(0) Executive summary – Dashboard  
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Situation and highlights 
Europe continues to show a 
situation where most countries 
have a ρ7 above 1. In particular, 
Spain and Denmark show 
values around 2. Living with the 
presence of the virus requires 
adjusting control measures to 
maintain a sustainable 
situation. It would be desirable 
to reduce the number of daily 
new cases to be at least in the 
situation of countries such as 
the Netherlands or Switzerland, 
which corresponds to reducing 
social contacts to reach a 
Biocom-Cov degree of 2. The 
value of A14 is quite high in a few 
countries, as well: Sweden (423 
per 105 inh.), Luxembourg (359), Romania (261), Belgium (241), Spain (228) and France (206). If these values 
decrease, these countries  will make it possible to control each of the cases and their contacts (test and trace 
strategy). 
The diagnostic effort in most European countries is currently higher than the one they had a few months ago. 
This means that the data on the number of daily new cases are not comparable with previous ones. We 
discuss this issue in the Analysis, and propose a simple method to allow comparison of new cases between 
different stages in the epidemic. 
A14 EPG 
  




(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends per country 
Table of current situation in EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, and distinguishes 
best (green) form worst (red) situations according to each of the variables. Last column (EPGEST) is assessed with estimated real 14-day attack rate (see report from 
22/04 for details). EPGREP is calculated with data reported by countries. EPGREP and EPGEST cannot be compared between them because scales are different, but can 
be independently used for estimating risk of countries according to reported or estimated real situation, respectively. Data from 2nd July.   
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Analysis: Index for the comparison among number of cases with different diagnosis 
rates in the same country at different times. 
From the beginning of the pandemic in March, the percentage of diagnosed cases has been, in general, 
continuously increasing in all the countries in the European Union. We have already studied such an increase 
in the reports #40 and #951. Next, we show a table where we show the evolution of the calculated diagnosis 
rate for different countries in the European Union. This table is the extension of the previous table shown 
in report #951, where we have also included Spain because it has finished with the checking of the number 
of deaths. Note that we estimate the total number from the number of deaths and therefore we need both 
quantities, number of cases and number of deaths. 
Table 1. Percentage of diagnosed cases from March to June (diagnostic rate, DR), monthly variation of these values and 
overall variation for EU+EFTA+UK countries 
 
 
The main reason for this trend has been the generalized increase in the number of tests performed. In the 
following two figures we can observe this issue. In Figure 1 we see the cumulative number of tests and cases 
per 100,000 inhabitants, and the ratio between these two variables for Austria, Belgium, Italy, Spain, 
Switzerland and the UK. It should be noted that the y-axis of the graph is logarithmic, and the differences in 
the final values are not easily ascertained (cumulative cases per 105 inhabitants: Austria 200, Belgium 540, 
Italy 400, Spain 530, UK 470). It is observed that, initially, the quotient between cases and test increases, 
and then, the rapid increase in the number of tests causes a progressive decrease in this ratio. 
 
                                                            
1 https://upcommons.upc.edu/handle/2117/184991, https://upcommons.upc.edu/handle/2117/191998 











Austria 17% 28% 11% 16% -12% 21% 5% 4%
Belgium 3% 5% 2% 9% 4% 13% 4% 10%
Bulgaria 12% 13% 2% 18% 5% 15% -4% 3%
Denmark 22% 15% -6% 28% 12% 36% 8% 14%
France 3% 5% 1% 7% 2% 13% 6% 9%
Germany 19% 23% 4% 17% -7% 23% 6% 4%
Greece 11% 18% 7% 15% -3% 19% 4% 8%
Hungary 3% 6% 3% 8% 2% 8% 0% 5%
Ireland 10% 12% 2% 19% 7% 14% -5% 4%
Italy 3% 8% 5% 9% 1% 8% -1% 5%
Netherlands 3% 7% 4% 11% 4% 21% 11% 19%
Poland 9% 14% 5% 21% 6% 30% 9% 21%
Portugal 4% 21% 17% 25% 4% 40% 15% 35%
Romania 8% 12% 4% 15% 3% 15% 0% 7%
Spain 2% 10% 8% 13% 3% 30% 17% 28%
Sweden 16% 5% -11% 9% 4% 21% 12% 5%
Switzerland 12% 21% 9% 14% -7% 18% 4% 6%
United Kingdom 1% 4% 3% 10% 6% 10% 0% 9%






Figure 1. Cumulative number of tests and cases per 100,000 inh. and quotient between both variables. 
 
These dynamics can be better visualized when we represent the daily testing level (DTL, tests performed daily 
per 100,000 inh.) and daily new cases per 100,000 hab. (Figure 2). Initially, the number of tests increased 
throughout the epidemic, but at a later stage we see how the DTL in some countries decreased or fluctuated. 
From the moment the tests were massively used (DTL of 100-150 between the different European 
countries), it is observed that the percentage of positive tests falls. In fact, at the beginning of the epidemic 
the number of cases detected depended largely on the tests performed and the percentage of positives was 
very high. The World Health Organization (WHO) has set a risk threshold based on the percentage of positives 
among performed tests, which WHO suggests that should be below 5 % for two weeks before reopening 
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countries2. Higher positive rates would indicate that testing effort is not enough and that a significant number 





Figure 2. Daily tests and cases per 100,000 inh. In black, quotient between both magnitudes. 
 
There is an important issue to keep in mind when assessing the percentage of positive tests: not all the tests 
are used to test new patients. In fact, a certain fraction of tests is used for checking the evolution of patients, 
in particular the negativization of the PCR. Therefore, the percentage of positive tests cannot be directly 
evaluated from the quotient between cases and tests. Italian government has published data that illustrates 
that between 50 and 60% of the tests are used to test new patient, while remaining tests are devoted to the 
follow-up of patients. This is shown in Figure 3.  
                                                            




Figure 3. Number of daily performed tests (blue) and number of new cases tested every day (red). Black line shows 
the quotient between both magnitudes. 
The increase in number of tests is essential to improve the picture of the situation and the control of the 
epidemics. Nevertheless, an increase in the diagnosis rate prevents current number of cases to be 
compared with those of previous stages of this epidemic. For instance, the 1,361 new cases that were 
registered in Spain on July 17 are not comparable to the 1,266 that were detected on March 14 in the same 
country. Next, we propose a new magnitude that pursues the validity of comparing of new cases along the 
epidemic: it consists of re-scaling the number of new cases (𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛) with the percentage of positive tests 
divided by WHO recommendation (5 %). Ideally, we should directly use the percentage of positives among 
tests performed to new patients. Nevertheless, while these data are not specifically reported by countries, 
the quotient between new cases and performed tests can be used instead. 
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛,𝑟𝑟𝑛𝑛−𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑛𝑛𝑠𝑠(𝑡𝑡) = 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡) ·
� 𝑛𝑛𝑛𝑛𝑛𝑛 𝑐𝑐𝑐𝑐𝑐𝑐𝑛𝑛𝑐𝑐𝑝𝑝𝑛𝑛𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑝𝑝 𝑡𝑡𝑛𝑛𝑐𝑐𝑡𝑡𝑐𝑐�𝑠𝑠𝑐𝑐𝑐𝑐𝑛𝑛𝑐𝑐𝑟𝑟𝑐𝑐,𝑐𝑐
� 𝑛𝑛𝑛𝑛𝑛𝑛 𝑐𝑐𝑐𝑐𝑐𝑐𝑛𝑛𝑐𝑐𝑝𝑝𝑛𝑛𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑝𝑛𝑛𝑝𝑝 𝑡𝑡𝑛𝑛𝑐𝑐𝑡𝑡𝑐𝑐�𝑟𝑟𝑛𝑛𝑟𝑟𝑛𝑛𝑟𝑟𝑛𝑛𝑛𝑛𝑠𝑠𝑛𝑛
 
Then, the re-scaled magnitude would permit the comparison of the situation at different stages of the 
epidemic. In other words, 10 new re-scaled cases now would be equivalent to 10 new re-scaled cases on 
March (Figure 4). 
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Figure 4. Re-scaled new cases in different European countries.  
 
This new variable allows us the drawing of a risk diagram that provides a more reliable history of the 
epidemic in a country, since it facilitates the numerical comparison between different stages in the epidemic. 
Figure 5 presents the comparison of both risk diagrams for Italy. In the left, the standard risk diagram that is 
plotted using reported data. In the right, a risk diagram which is plotted using re-scaled new cases instead of 
reported. The colour code in the new risk diagram is still to be defined, since its meaning (possibility of tracing 
contacts with current DTL) is not directly exportable to the new one and requires further analysis.  
  
Figure 5. Risk diagram of Italy (left) and risk diagram using re-scaled new cases (right). 
 
In conclusion, the diagnosis rate has been continuously increasing during the last month. This is because the 
number of tests has increased during the pandemic while the number of cases has strongly decreased. These 
new tests actually refer not only to new cases but also because of the evolution of the patients as we have 
from the Italian case. We can finally define a rescaled number of cases, taking into account the number of 
tests. Such index permits to compare the situation corresponding to the new cases detected now in 
comparison with the cases detected some months ago. 
9
(1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the product of attack-rate of last 14 days per 105 inhabitants by 
ρ7 (empiric reproduction number). EPGEST is the product of estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, https://upcommons.upc.edu/handle/2117/189808). 
 
Situation and trends in other countries 
Table of current situation in a sample of non-EU countries. Colour scale is relative except when indicated, this means that it is applied independently to each column, 
and distinguishes best (green) form worst (red) situations according to each of the variables. EPGREP and EPGEST cannot be compared between them because scales 
are different, but can be independently used for estimating risk of countries according to reported or estimated real situation, respectively. Data from 2nd July.   
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see report from 20 to 24 April, #37-41). This value can change in 




Time indicators by country 
These tables summarize a few time indicators for each country: time since 50 cases were reported, time 
interval between an attack rate of 1/105 inhabitants and an attack rate of 10/105 inhabitants, and time 
interval between attack rates of 10 to 100 per 105 inhabitants (only for countries that have overtaken this 




















Evaluated with the whole historical series. Up-left: Predictions of maximum incidences per country at the 
end of the first wave (total final expected attack rate per 105 inh.). Up-right: Predictions of maximum 
absolute number of cases per country at the end of the first wave (K, in log scale). Blue lines indicate current 
situation. Bottom-left: Time in which peak in new cases was achieved / will be achieved. Bottom-right: Time 
at which 90 % of K was achieved / will be achieved. Blue dotted line indicates current date.  
 
Final expected value for EU+EFTA+UK as a whole is not shown any more, since we are in the tail (see 










Situation and trends in Italian and Spanish regions 
Italy 
Data from 20th July 
 
Spain  
Data from 10th July. Symptoms onset date. 
 
Disclaimer: estimated active cases and estimated 14-day attack rate are assessed by assuming a lethality of 1 % (see 
report from 20 to 24 April, #37-41). This value can change in countries where suspicious deaths are reported as well 
(real values would be lower) and in countries where incidence among elderly people was minor (real values would be 
higher).  
 (1) ρ7 is the average of 7 consecutive ρ, but can still fluctuate. (2,3) EPG stands for Effective Growth Potential. EPGREP is the 
product of attack-rate of last 14 days per 105 inhabitants by ρ7 (empiric reproduction number). EPGEST is the product of 
estimated real attack-rate of last 14 days per 105 inhabitants and ρ7. Biocom-Cov degree is an epidemiological situation 
scale based on the level of last week’s mean daily new cases (https://upcommons.upc.edu/handle/2117/189661, 
https://upcommons.upc.edu/handle/2117/189808). 
 
Long-term predictions are not shown any more, since all Italian and Spanish regions are already in the tail 




Legend: Countries’ reports details 

























reported cases.  
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Risk diagram of 


































Data obtained from  https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 

































































Data obtained from https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases  
 
(2) Analysis and prediction of COVID-19 


























 Data obtained from: https://github.com/pcm-dpc/COVID-19/tree/master/dati-andamento-nazionale 
(3) Analysis and prediction of COVID-19

























































(1) Data source 
Data are daily obtained from World Health Organization (WHO) surveillance reports3, from European Centre 
for Disease Prevention and Control (ECDC)4 and from Ministerio de Sanidad5. These reports are converted 
into text files that can be processed for subsequent analysis. Daily data comprise, among others: total 
confirmed cases, total confirmed new cases, total deaths, total new deaths. It must be considered that the 
report is always providing data from previous day. In the document we use the date at which the datapoint 
is assumed to belong, i.e., report from 15/03/2020 is giving data from 14/03/2020, the latter being used in 
the subsequent analysis.  
(2) Data processing and plotting 
Data are initially processed with Matlab in order to update timeseries, i.e., last datapoints are added to 
historical sequences. These timeseries are plotted for EU individual countries and for the UE as a whole: 
 Number of cumulated confirmed cases, in blue dots 
 Number of reported new cases 
 Number of cumulated deaths  
Then, two indicators are calculated and plotted, too: 
 Number of cumulated deaths divided by the number of cumulated confirmed cases, and reported as 
a percentage; it is an indirect indicator of the diagnostic level. 
 ρ: this variable is related with the reproduction number, i.e., with the number of new infections 
caused by a single case. It is evaluated as follows for the day before last report (t-1): 
𝜌𝜌(𝑡𝑡 − 1) =
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 1) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 2)
𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 5) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 6) + 𝑁𝑁𝑛𝑛𝑛𝑛𝑛𝑛(𝑡𝑡 − 7)
 
where Nnew(t) is the number of new confirmed cases at day t.  
(3) Classification of countries according to their status in the epidemic cycle 
The evolution of confirmed cases shows a biphasic behaviour:  
(I) an initial period where most of the cases are imported; 
(II) a subsequent period where most of new cases occur because of local transmission.  
Once in the stage II, mathematical models can be used to track evolutions and predict tendencies. Focusing 
on countries that are on stage II, we classify them in three groups: 
• Group A: countries that have reported more than 100 cumulated cases for 10 consecutive days or 
more; 
• Group B: countries that have reported more than 100 cumulated cases for 7 to 9 consecutive days; 
• Group C: countries that have reported more than 100 cumulated cases for 4 to 6 days. 
 








(4) Fitting a mathematical model to data 
Previous studies have shown that Gompertz model6 correctly describes the Covid-19 epidemic in all analysed 
countries. It is an empirical model that starts with an exponential growth but that gradually decreases its 
specific growth rate. Therefore, it is adequate for describing an epidemic that is characterized by an initial 
exponential growth but a progressive decrease in spreading velocity provided that appropriate control 
measures are applied.   
Gompertz model is described by the equation:  





where N(t) is the cumulated number of confirmed cases at t (in days), and N0 is the number of cumulated 
cases the day at day t0. The model has two parameters: 
 a is the velocity at which specific spreading rate is slowing down; 
 K is the expected final number of cumulated cases at the end of the epidemic. 
This model is fitted to reported cumulated cases of the UE and of countries in stage II that accomplish two 
criteria: 4 or more consecutive days with more than 100 cumulated cases, and at least one datapoint over 
200 cases. Day t0 is chosen as that one at which N(t) overpasses 100 cases. If more than 15 datapoints that 
accomplish the stated criteria are available, only the last 15 points are used. The fitting is done using Matlab’s 
Curve Fitting package with Nonlinear Least Squares method, which also provides confidence intervals of 
fitted parameters (a and K) and the R2 of the fitting. At the initial stages the dynamics is exponential and K 
cannot be correctly evaluated. In fact, at this stage the most relevant parameter is a. Fitted curves are 
incorporated to plots of cumulative reported cases with a dashed line. Once a new fitting is done, two plots 
are added to the country report: 
 Evolution of fitted a with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out;  
 Evolution of fitted K with its error bars, i.e., values obtained on the fitting each day that the analysis 
has been carried out; if lower error bar indicates a value that is lower than current number of cases, 
the error bar is truncated. 
These plots illustrate the increase in fittings’ confidence, as fitted values progressively stabilize around a 
certain value and error bars get smaller when the number of datapoints increases. In fact, in the case of 
countries, they are discarded and set as “Not enough data” if a>0.2 day-1, if K>106 or if the error in K 
overpasses 106. 
It is worth to mention that the simplicity of this model and the lack of previous assumptions about the Covid-
19 behaviour make it appropriate for universal use, i.e., it can be fitted to any country independently of its 
socioeconomic context and control strategy. Then, the model is capable of quantifying the observed 
dynamics in an objective and standard manner and predicting short-term tendencies.  
(5) Using the model for predicting short-term tendencies 
The model is finally used for a short-term prediction of the evolution of the cumulated number of cases. The 
predictions increase their reliability with the number of datapoints used in the fitting. Therefore, we consider 
three levels of prediction, depending on the country: 
                                                            




• Group A: prediction of expected cumulated cases for the following 3-5 days7; 
• Group B: prediction of expected cumulated cases for the following 2 days; 
• Group C: prediction of expected cumulated cases for the following day. 
The confidence interval of predictions is assessed with the Matlab function predint, with a 99% confidence 
level. These predictions are shown in the plots as red dots with corresponding error bars, and also gathered 
in the attached table. For series longer than 9 timepoints, last 3 points are weighted in the fitting so that 
changes in tendencies are well captured by the model. 
(6) Estimating non-diagnosed cases 
Lethality of Covid-19 has been estimated at around 1 % for Republic of Korea and the Diamond Princess 
cruise. Besides, median duration of viral shedding after Covid-19 onset has been estimated at 18.5 days for 
non-survivors8 in a retrospective study in Wuhan. These data allow for an estimation of total number of 
cases, considering that the number of deaths at certain moment should be about 1 % of total cases 18.5 days 
before. This is valid for estimating cases of countries at stage II, since in stage I the deaths would be mostly 
due to the incidence at the country from which they were imported. We establish a threshold of 50 reported 
cases before starting this estimation.  
Reported deaths are passed through a moving average filter of 5 points in order to smooth tendencies. Then, 
the corresponding number of cases is found assuming the 1 % lethality. Finally, these cases are distributed 
between 18 and 19 days before each one.  
 
                                                            
7 At this moment we are testing predictions at 4 days for countries with more than 100 cumulated cases for 13-15 
consecutive days, and 5 days for 16 or more days.  
8 Zhou et al., 2020. Clinical course and risk factors for mortality of adult 
inpatients with COVID-19 in Wuhan, China: a retrospective 
cohort study. The Lancet; March 9, doi: 10.1016/S0140-6736(20)30566-3 
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